Resultats de la cerca - Andrea Navarria
- Mostrar 1 - 8 resultats de 8
-
1
-
2
-
3
-
4
-
5
Efficacy and Hypoglycemia Profile of Once-Weekly Insulin Icodec vs. Once-Daily Comparators across Demographic Subgroups per Ildiko Lingvay, Julie Krogsdahl Bache, Cyrus Desouza, Mariana Fragão-Marques, Andrea Navarria, Shehla Shaikh, André Gustavo Daher Vianna
Publicat 2025Artigo -
6
Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses per Bhavya Voleti, Andrea Navarria, Rong-Jian Liu, Mounira Banasr, Nanxin Li, Rose Z. Terwilliger, Gerard Sanacora, Tore Eid, George K. Aghajanian, Ronald S. Duman
Publicat 2013Artigo -
7
Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors per Andrea Navarria, Eric S. Wohleb, Bhavya Voleti, Kristie T. Ota, Sophie Dutheil, Ashley E. Lepack, Jason M. Dwyer, Manabu Fuchikami, Astrid Becker, Filippo Drago, Ronald S. Duman
Publicat 2015Artigo -
8
Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial per Yuichiro Yamada, Hideki Katagiri, Yoshiyuki Hamamoto, Srikanth Deenadayalan, Andrea Navarria, Keiji Nishijima, Yutaka Seino, Yasushi Fukushima, Yoshiyuki Hamamoto, Hisatomi Arima, Yumiko Ide, Satoshi Inoue, Tatsushi Kawada, H Kim, Arihiro Kiyosue, K Matoba, Osamu Matsuoka, H. Nishimura, Masahiro Noguchi, Takeshi Osonoi, Shojiro Sawada, Yoshiyuki Shibasaki, Koki Shin, Yuichiro Yamada
Publicat 2020Artigo
Eines de cerca:
Matèries relacionades
Medicine
Diabetes mellitus
Endocrinology
Internal medicine
Type 2 diabetes
Liraglutide
Pharmacology
Semaglutide
Adverse effect
Dulaglutide
Oral administration
Pharmacokinetics
Alternative medicine
Antagonist
Biology
Environmental health
Neuroscience
Pathology
Placebo
Population
Receptor
Acetylcholine
Anthropology
Antidepressant
Bioavailability
Biochemistry
Body weight
Cell biology
Cholinergic
Clinical endpoint